"Nasal Sprays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pharmacologic agents delivered into the nostrils in the form of a mist or spray.
MeSH Number(s)
D20.280.055.500
D26.255.165.055.291
Concept/Terms
Nasal Sprays- Nasal Sprays
- Sprays, Nasal
- Nasal Mist
- Mist, Nasal
- Nasal Aerosol
- Aerosol, Nasal
Below are MeSH descriptors whose meaning is more general than "Nasal Sprays".
Below are MeSH descriptors whose meaning is more specific than "Nasal Sprays".
This graph shows the total number of publications written about "Nasal Sprays" by people in Harvard Catalyst Profiles by year, and whether "Nasal Sprays" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 2 | 2 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2021 | 0 | 3 | 3 |
2022 | 1 | 4 | 5 |
2023 | 0 | 3 | 3 |
Below are the most recent publications written about "Nasal Sprays" by people in Profiles.
-
Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance. Curr Med Res Opin. 2023 08; 39(8):1167-1174.
-
Concomitant cannabidiol does not impact safety and effectiveness of diazepam nasal spray for seizure clusters: Post hoc analysis of a phase 3 safety study. Epilepsy Behav. 2023 Jul; 144:109248.
-
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States. J Med Econ. 2023 Jan-Dec; 26(1):691-700.
-
Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States. Clin Ther. 2022 Nov; 44(11):1432-1448.
-
A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID. Trials. 2022 Sep 15; 23(1):782.
-
Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters. Epilepsia. 2022 10; 63(10):2684-2693.
-
Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders. Harm Reduct J. 2022 05 20; 19(1):49.
-
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior. J Comp Eff Res. 2022 04; 11(5):319-328.
-
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials. Arch Womens Ment Health. 2022 04; 25(2):313-326.
-
Review of the use of nasal and oral antiseptics during a global pandemic. Future Microbiol. 2021 01; 16:119-130.